Work

Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti–tumor necrosis factor antibody, in Phase III clinical trials

Year: 2012

Type: article

Source: Arthritis Care & Research

DOI: 10.1002/acr.21788

Authors: Elizabeth C. Hsia, John J. Cush, Eric L. Matteson, Anna Beutler, Mittie K. Doyle, Benjamin Hsu, Stephen Xu, Mahboob U. Rahman

Institutions: Johnson & Johnson (United States), Janssen Research & Development (United States), University of Pennsylvania, Baylor University Medical Center, Mayo Clinic, Alexion Pharmaceuticals (United States), Pfizer (United States)

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2023585231

FWCI: 7.067

Cites: 8

Cited by: 56

Related to: 10